Amarantus Bioscience Holdings Inc (OTC Pink - Current Information:AMBS)

0.0434
Delayed Data
As of Apr 18
 -0.0021 / -4.62%
Today’s Change
0.01
Today|||52-Week Range
0.21
-69.22%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$8.9M

Company Description

Amarantus BioScience Holdings, Inc. is a publicly traded biotechnology company focused on developing therapeutic products with the potential for orphan drug designation in the areas of neurology, psychiatry, ophthalmology and regenerative medicine, and diagnostics in neurology. The company was founded by Gerald E. Commissiong and John W. Commissiong on January 14, 2008 and is headquartered in San Francisco, CA.

Contact Information

Amarantus Bioscience Holdings, Inc.
655 Montgomery Street
San Francisco California 94111
P:(415) 688-4484
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Gerald E. CommissiongPresident, Chief Executive Officer & Director
Barney MonteChief Operating & Financial Officer
John W. CommissiongDirector & Chief Scientific Officer
Robert L. HarrisCompliance Officer
Elise BrownellSenior VP-Operations & Program Management